This company listing is no longer active
Acerus Pharmaceuticals Future Growth
Future criteria checks 0/6
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 56.3% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Auditors Have Doubts About Acerus Pharmaceuticals (TSE:ASP)
Mar 14
Have Insiders Been Buying Acerus Pharmaceuticals Corporation (TSE:ASP) Shares?
Mar 12Acerus Pharmaceuticals' (TSE:ASP) Shareholders Are Down 88% On Their Shares
Jan 22The Independent Director of Acerus Pharmaceuticals Corporation (TSE:ASP), Stephen Gregory, Just Bought 52% More Shares
Nov 30
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Acerus Pharmaceuticals has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2022 | 3 | -28 | -28 | -26 | N/A |
| 6/30/2022 | 3 | -29 | -24 | -22 | N/A |
| 3/31/2022 | 3 | -28 | -25 | -24 | N/A |
| 12/31/2021 | 2 | -34 | -24 | -24 | N/A |
| 9/30/2021 | 2 | -32 | -21 | -21 | N/A |
| 6/30/2021 | 2 | -34 | -24 | -24 | N/A |
| 3/31/2021 | 1 | -33 | -21 | -21 | N/A |
| 12/31/2020 | 1 | -24 | -22 | -22 | N/A |
| 9/30/2020 | 1 | -21 | -22 | -22 | N/A |
| 6/30/2020 | 1 | -19 | -17 | -17 | N/A |
| 3/31/2020 | 2 | -16 | -14 | -14 | N/A |
| 12/31/2019 | 4 | -16 | -11 | -11 | N/A |
| 9/30/2019 | 5 | -17 | -8 | -8 | N/A |
| 6/30/2019 | 7 | -16 | -9 | -9 | N/A |
| 3/31/2019 | 8 | -19 | -8 | -8 | N/A |
| 12/31/2018 | 7 | -19 | -6 | -6 | N/A |
| 9/30/2018 | 8 | -16 | -6 | -6 | N/A |
| 6/30/2018 | 7 | -16 | -4 | -4 | N/A |
| 3/31/2018 | 7 | -11 | -3 | -3 | N/A |
| 12/31/2017 | 7 | -9 | 0 | 0 | N/A |
| 9/30/2017 | 6 | -7 | 2 | 2 | N/A |
| 6/30/2017 | 6 | -5 | 3 | 3 | N/A |
| 3/31/2017 | 15 | 3 | 5 | 5 | N/A |
| 12/31/2016 | 24 | 11 | 3 | 3 | N/A |
| 9/30/2016 | 31 | 3 | 0 | 0 | N/A |
| 6/30/2016 | 32 | 5 | N/A | 2 | N/A |
| 3/31/2016 | 24 | -3 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if ASP's forecast earnings growth is above the savings rate (1.8%).
Earnings vs Market: Insufficient data to determine if ASP's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if ASP's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if ASP's revenue is forecast to grow faster than the Canadian market.
High Growth Revenue: Insufficient data to determine if ASP's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ASP's Return on Equity is forecast to be high in 3 years time